Cargando…
Salt-inducible kinase 2 (SIK2) inhibitor ARN-3236 attenuates bleomycin-induced pulmonary fibrosis in mice
BACKGROUND: Pulmonary fibrosis is a fatal lung disease with complex pathogenesis and limited effective therapies. Salt-inducible kinase 2 (SIK2) is a kinase that phosphorylates CRTCs and regulates many physiological processes. However, the role of SIK2 on pulmonary fibrosis remains unclear, and whet...
Autores principales: | Zou, Liangneng, Hong, Dequn, Li, Kecong, Jiang, Bingyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004037/ https://www.ncbi.nlm.nih.gov/pubmed/35410283 http://dx.doi.org/10.1186/s12890-022-01940-0 |
Ejemplares similares
-
The Selective SIK2 Inhibitor ARN-3236 Produces Strong Antidepressant-Like Efficacy in Mice via the Hippocampal CRTC1-CREB-BDNF Pathway
por: Liu, Yue, et al.
Publicado: (2021) -
Nuts and bolts of the salt-inducible kinases (SIKs)
por: Darling, Nicola J., et al.
Publicado: (2021) -
Salt-inducible kinases (SIK) inhibition reduces RANKL-induced osteoclastogenesis
por: Lombardi, Maria Stella, et al.
Publicado: (2017) -
Salt-inducible kinase 2 regulates fibrosis during bleomycin-induced lung injury
por: van Gijsel-Bonnello, Manuel, et al.
Publicado: (2022) -
The potent roles of salt-inducible kinases (SIKs) in metabolic homeostasis and tumorigenesis
por: Sun, Zicheng, et al.
Publicado: (2020)